Under normal market conditions, the Fund will invest at least 80 percentage of its net assets (plus any borrowings for investment purposes) in common stock and depository receipts issued by US and non-US companies that may benefit from the development or application of scientific and technological innovation. This includes, but is not limited to, companies that are poised to benefit from new products or services, scientific research, technological improvements and/or enhancements to existing products or services related to automation, advanced medicine, networks, advanced computing, enhanced mobility, energy revolution and e-commerce.